Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
xaNA0AYR0G9Qs5tb
Français